Journal of Korean Neurosurgical Society

  • 제56권3호
  • /
  • Pages.194-199
  • /
  • 2014
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features and Treatment Outcome of Chordoid Meningiomas in a Single Institute

  • Jee, Tae Keun (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jo, Kyung-Il (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Seol, Ho Jun (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kong, Doo-Sik (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Jung-Il (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shin, Hyung Jin (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2014.05.15
  • 심사 : 2014.09.06
  • 발행 : 2014.09.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Meningioma is the second most common primary central nervous system neoplasm. In contrast, chordoid meningioma is rare; due to the paucity of cases, little is known about its clinical features or treatment outcomes. The objectives of this study were to describe the clinical characteristics and outcomes for patients with chordoid meningioma. Methods : In total, 16 patients, with newly diagnosed chordoid meningioma who underwent surgical excision between 1999 and 2012 were included. We retrospectively evaluated the medical records, radiological findings, and pathological findings. The median follow-up period was 56.5 (range, 3-170) months. The MIB-1 labeling index ranged from 1 to 26.60% (median, 5.04). Results : Simpson grade I, II, and III resections were performed in four, nine, and three patients, respectively. The overall recurrence rate was 37.5%. Overall progression-free survival (PFS) after resection was 94.7 months (95% CI=62.9-126.6). Of the 4 patients with Simpson grade I resection, recurrence occurred in one patient. Among the Simpson grade II and III resection groups, eight patients underwent adjuvant radiation therapy and they showed significantly longer PFS (121 months, 95% CI=82.1-159.9) than the patients who underwent surgery alone (40.5 months, 95% CI=9.6-71.3) by the log-rank test (p<0.05). Conclusion : Chordoid meningiomas are difficult to manage and have a high rate of recurrence. Complete resection of the tumor is a key determinant of better outcomes. Adjuvant radiation therapy is recommended, eparticulary when Simpson grade I resection was not achieved.

키워드

참고문헌

  1. Amatya VJ, Takeshima Y, Sugiyama K, Kurisu K, Nishisaka T, Fukuhara T, et al. : Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 32 : 970-975, 2001 https://doi.org/10.1053/hupa.2001.27119
  2. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM : Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20 : 525-528, 1987 https://doi.org/10.1227/00006123-198704000-00003
  3. Choi KC, Joo WI, Jang KS, Kim MC : Chordoid meningioma. J Korean Neurosurg Soc 38 : 390-392, 2005
  4. Goldsmith BJ, Wara WM, Wilson CB, Larson DA : Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80 : 195-201, 1994 https://doi.org/10.3171/jns.1994.80.2.0195
  5. Ho DM, Hsu CY, Ting LT, Chiang H : Histopathology and MIB-1 labeling index predicted recurrence of meningiomas : a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94 : 1538-1547, 2002 https://doi.org/10.1002/cncr.10351
  6. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. : Management of atypical and malignant meningiomas : role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48 : 151-160, 2000 https://doi.org/10.1023/A:1006434124794
  7. Jaaskelainen J, Haltia M, Servo A : Atypical and anaplastic meningiomas : radiology, surgery, radiotherapy, and outcome. Surg Neurol 25 : 233-242, 1986 https://doi.org/10.1016/0090-3019(86)90233-8
  8. Jeon CJ, Kim MJ, Lee JS, Lee JH, Kong DS, Shin HJ, et al. : Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia. Childs Nerv Syst 26 : 1647-1652, 2010 https://doi.org/10.1007/s00381-010-1196-9
  9. Jo KW, Kim CH, Kong DS, Seol HJ, Nam DH, Park K, et al. : Treatment modalities and outcomes for asymptomatic meningiomas. Acta Neurochir (Wien) 153 : 62-67; discussion 67, 2011 https://doi.org/10.1007/s00701-010-0841-0
  10. Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T : Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29 : 293-296; discussion 296-297, 2006 https://doi.org/10.1007/s10143-006-0039-3
  11. Konstantinidou AE, Korkolopoulou P, Kavantzas N, Mahera H, Thymara I, Kotsiakis X, et al. : Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas. Histol Histopathol 18 : 67-74, 2003
  12. Kozler P, Benes V, Netuka D, Kramar F, Hrabal P, Charvat F : Chordoid meningioma : presentation of two case reports, review of the literature, and plea for data standardisation. J Neurooncol 88 : 115-120, 2008 https://doi.org/10.1007/s11060-008-9541-5
  13. Lin JW, Lu CH, Lin WC, Wu YT, Huang YJ, Shih FY, et al. : A clinicopathological study of the significance of the proportion of choroid morphology in chordoid meningioma. J Clin Neurosci 19 : 836-843, 2012 https://doi.org/10.1016/j.jocn.2011.08.037
  14. Ludemann WO, Obler R, Tatagiba M, Samii M : Seeding of malignant meningioma along a surgical trajectory on the scalp. Case report and review of the literature. J Neurosurg 97 : 683-686, 2002 https://doi.org/10.3171/jns.2002.97.3.0683
  15. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al. : Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91 : 504-510, 1996 https://doi.org/10.1007/s004010050458
  16. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, et al. : Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106 : 776-781, 1996 https://doi.org/10.1093/ajcp/106.6.776
  17. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, et al. : Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85 : 2249-2254, 1999 https://doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2249::AID-CNCR21>3.0.CO;2-5
  18. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M : Significance of MIB-1 staining indices in meningiomas : comparison of two counting methods. Am J Surg Pathol 25 : 472-478, 2001 https://doi.org/10.1097/00000478-200104000-00006
  19. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM : The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82 : 2262-2269, 1998 https://doi.org/10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R
  20. Sadahira Y, Sugihara K, Manabe T : Iatrogenic implantation of malignant meningioma to the abdominal wall. Virchows Arch 438 : 316-318, 2001 https://doi.org/10.1007/s004280000347
  21. Sandberg DI, Edgar MA, Resch L, Rutka JT, Becker LE, Souweidane MM : MIB-1 staining index of pediatric meningiomas. Neurosurgery 48 : 590-595; discussion 595-597, 2001 https://doi.org/10.1097/00006123-200103000-00027
  22. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 : 22-39, 1957 https://doi.org/10.1136/jnnp.20.1.22
  23. Strik HM, Strobelt I, Pietsch-Breitfeld B, Iglesias-Rozas JR, Will B, Meyermann R : The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. In Vivo 16 : 265-270, 2002
  24. Tena-Suck ML, Collado-Ortiz MA, Salinas-Lara C, Garcia-Lopez R, Gelista N, Rembao-Bojorquez D : Chordoid meningioma : a report of ten cases. J Neurooncol 99 : 41-48, 2010 https://doi.org/10.1007/s11060-009-0097-9
  25. Wang XQ, Mei GH, Zhao L, Li ST, Gong Y, Zhong J, et al. : Clinical features and treatment of intracranial chordoid meningioma : a report of 30 cases. Histopathology 62 : 1002-1017, 2013 https://doi.org/10.1111/his.12113
  26. Whittle IR, Smith C, Navoo P, Collie D : Meningiomas. Lancet 363 : 1535-1543, 2004 https://doi.org/10.1016/S0140-6736(04)16153-9
  27. Yoneoka Y, Fujii Y, Tanaka R : Growth of incidental meningiomas. Acta Neurochir (Wien) 142 : 507-511, 2000 https://doi.org/10.1007/s007010050463

피인용 문헌

  1. Chordoid meningioma: a clinico-pathological study of an uncommon variant of meningioma vol.137, pp.3, 2014, https://doi.org/10.1007/s11060-018-2748-1
  2. Foramen Magnum Chordoid Meningioma in a 22-Year-old Female vol.13, pp.3, 2014, https://doi.org/10.4103/ajns.ajns_296_16
  3. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma vol.43, pp.9, 2014, https://doi.org/10.1097/rlu.0000000000002233
  4. A Case of Tuberculum Sellae Chordoid Meningioma Treated via Extended Endoscopic Endonasal Trans-sphenoidal Surgery vol.7, pp.2, 2020, https://doi.org/10.2176/nmccrj.cr.2019-0083